Pharvaris N.V. (PHVS)
15.02
0.19 (1.28%)
At close: Apr 02, 2025, 11:25 AM
Pharvaris Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 252.27K | 150.19K | 80.46K | n/a | 547.41 | n/a |
| Gross Profit | -252.27K | -150.19K | -80.46K | n/a | -547.41 | n/a |
| Operating Income | -96.91M | -86.74M | -65.9M | -25.01M | -7.99M | -4.31M |
| Interest Income | n/a | 16.11 | 267.51 | 92.47 | 4.38 | n/a |
| Pretax Income | -99.83M | -75.65M | -42.66M | -26.07M | -8.03M | -4.31M |
| Net Income | -100.88M | -76.33M | -42.73M | -25.99M | -8.04M | -4.31M |
| Selling & General & Admin | 31.34M | 29.34M | 18.35M | 5.5M | 2.33M | 668.12K |
| Research & Development | 65.58M | 57.38M | 35.79M | 19.51M | 5.68M | 3.65M |
| Other Expenses | -0.00 | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 96.91M | 86.71M | 54.14M | 25.01M | 8.01M | 4.31M |
| Interest Expense | 20.05K | 16.11K | 278.18K | 92.47K | n/a | n/a |
| Selling & Marketing Expenses | 200K | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 96.91M | 86.71M | 54.14M | 25.01M | 8.01M | 4.31M |
| Income Tax | 1.05M | 679.09K | 70.12K | -83.25K | 16.88K | 380.00 |
| Shares Outstanding (Basic) | 38.39M | 33.59M | 30.41M | 30.52M | 4.85M | 31.84M |
| Shares Outstanding (Diluted) | 38.39M | 33.59M | 30.41M | 30.52M | 4.85M | 31.84M |
| EPS (Basic) | -2.63 | -2.27 | -1.41 | -0.85 | -1.66 | -0.14 |
| EPS (Diluted) | -2.63 | -2.27 | -1.41 | -0.85 | -1.66 | -0.14 |
| EBITDA | -96.85M | -86.58M | -54.06M | -25.01M | -8.01M | -4.31M |
| EBIT | -96.91M | -86.71M | -54.14M | -25.01M | -8.01M | -4.31M |
| Depreciation & Amortization | 59.78K | 150.19K | 80.46K | 7.4K | 547.41 | 4.31M |